23 February 2026 - Top Stories

AI moves from pilots to frontline care in Australia, delivering real productivity gains for carers. Uniting NSW & ACT has rolled Buddy out to 1,000 community care workers, slashing admin time and speeding notes. Post-visit documentation dropped from around 10–20 minutes to about 0.5–1 minute, with staff reclaiming one to two hours daily for care delivery. Buddy is framed as augmentation, not replacement, and the rollout followed discovery work that started with 50 use cases and narrowed to three live options. The mobile app supports 50 languages, with translations flowing into notes and workflows.

Alcidion has gained Class 1 regulatory clearance for Concept Detection within the Miya Precision platform’s Noting module. The Australian-listed device reads clinicians’ free text to surface medical concepts and suggests SNOMED CT codes, supporting structured documentation and faster workflows. It also holds Class 1 status from the UK regulator. Clinicians must review all detected concepts before they are added to records, reinforcing governance around AI-assisted coding.

Australia’s health sector was the top cyber threat target in the second half of 2025, Nozomi Networks Labs reports. Healthcare led targeted alerts and ranked third for alerts per organisation, up from fourth earlier in 2025. The results underline a growing attack surface and the need for improved visibility and smarter resilience across health tech players and digital infrastructure.

Digital nudges are gaining traction. A large Australian trial across 20 clinics tested SMS reminders to improve timely childhood vaccination. About 9,993 parents were enrolled and roughly 11,500 children were due for at least one dose. Participants were exposed to 12 message variants at different timings. The automated approach showed potential to boost timeliness and could be scaled across GP networks.

A small Flinders University study suggests a less invasive option for sleep apnoea. Percutaneous hypoglossal nerve stimulation involved a subcutaneous electrode array stimulating the tongue during sleep. Breathing improved in 93% of the 14 participants, with airflow gains comparable to CPAP, hinting at wider access if validated in larger trials.

Queensland real-world data show a drop in infant RSV detections after Beyfortus rollout began in 2024. In a study of about 21,000 tests, infants three months or younger had an absolute risk reduction of 6.9 percentage points. Positive tests fell from 16% to 5.8% in eligible infants, while ineligible older children declined from 18.6% to 14.6%, illustrating the programme’s community impact.

• Buddy AI deployed to 1,000 carers, delivering 1–2 hours daily back to front-line care.
• Concept Detection cleared in Australia and the UK, enabling AI-assisted coding with clinician validation.
• Health sector emerges as a top cyber target, driving emphasis on visibility and resilience.
• SMS reminders show scalable potential to improve vaccination timeliness in primary care.
• Percutaneous nerve stimulation offers a less invasive sleep apnoea option with strong early results.
• Beyfortus rollout correlates with real-world RSV reductions in infants, supported by large-scale testing data.